FUN
5-(AMINOSULFONYL)-4-CHLORO-2-[(2-FURYLMETHYL)AMINO]BENZOIC ACID
Created: | 2005-09-13 |
Last modified: | 2021-03-01 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 32 |
Chiral Atom Count | 0 |
Bond Count | 33 |
Aromatic Bond Count | 11 |
Chemical Component Summary | |
---|---|
Name | 5-(AMINOSULFONYL)-4-CHLORO-2-[(2-FURYLMETHYL)AMINO]BENZOIC ACID |
Synonyms | Furosemide |
Systematic Name (OpenEye OEToolkits) | 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoyl-benzoic acid |
Formula | C12 H11 Cl N2 O5 S |
Molecular Weight | 330.744 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | O=S(=O)(N)c1c(Cl)cc(c(C(=O)O)c1)NCc2occc2 |
SMILES | CACTVS | 3.370 | N[S](=O)(=O)c1cc(C(O)=O)c(NCc2occc2)cc1Cl |
SMILES | OpenEye OEToolkits | 1.7.0 | c1cc(oc1)CNc2cc(c(cc2C(=O)O)S(=O)(=O)N)Cl |
Canonical SMILES | CACTVS | 3.370 | N[S](=O)(=O)c1cc(C(O)=O)c(NCc2occc2)cc1Cl |
Canonical SMILES | OpenEye OEToolkits | 1.7.0 | c1cc(oc1)CNc2cc(c(cc2C(=O)O)S(=O)(=O)N)Cl |
InChI | InChI | 1.03 | InChI=1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19) |
InChIKey | InChI | 1.03 | ZZUFCTLCJUWOSV-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank ID | DB00695 |
---|---|
Name | Furosemide |
Groups |
|
Description | Furosemide is a potent loop diuretic that acts on the kidneys to ultimately increase water loss from the body. It is an anthranilic acid derivative.[L7958] Furosemide is used for edema secondary to various clinical conditions, such as congestive heart failure exacerbation, liver failure, renal failure, and high blood pressure.[L7961] It mainly works by inhibiting electrolyte reabsorption from the kidneys and enhancing the excretion of water from the body. Furosemide has a fast onset and short duration of action and has been used safely and effectively in both pediatric and adult patients.[A182495] The use of furosemide is particularly beneficial in clinical settings that require a drug with a higher diuretic potential. In addition to oral formulations, the solution for intravenous and intramuscular administration is also available, which is typically limited to patients who are unable to take oral medication or for patients in emergency clinical situations.[L7958] |
Synonyms |
|
Brand Names |
|
Indication | Furosemide is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients.[L7958] Oral furosemide is indicated alone for the management of mild to moderate hypertension or severe hypertension in combination with other antihypertensive medications.[L9659] Intravenous furosemide is indicated as adjunctive therapy in acute pulmonary edema when a rapid onset of diuresis is desired.[L7958] Subcutaneous furosemide is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure. This drug formulation is not indicated for emergency situations or in patients with acute pulmonary edema.[L43408] |
Categories |
|
ATC-Code |
|
CAS number | 54-31-9 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Solute carrier family 12 member 1 | MSLNNSSNVFLDSVPSNTNRFQVSVINENHESSAAADDNTDPPHYEETSF... | unknown | inhibitor |
Carbonic anhydrase 2 | MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS... | unknown | inhibitor |
G-protein coupled receptor 35 | MNGTYNTCGSSDLTWPPAIKLGFYAYLGVLLVLGLLLNSLALWVFCCRMQ... | unknown | agonist |
6-phosphogluconate dehydrogenase, decarboxylating | MAQADIALIGLAVMGQNLILNMNDHGFVVCAFNRTVSKVDDFLANEAKGT... | unknown | inhibitor |
UDP-glucuronosyltransferase 1A1 | MAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQL... | unknown | substrate |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL35 |
PubChem | 3440, 118985385 |
ChEMBL | CHEMBL35 |
ChEBI | CHEBI:47426 |
CCDC/CSD | FURSEM03, XUDYED, TARPOU, BOKHAM02, BOKHAM01, LODFUH, YASGOQ03, BOKHUG, LOFLID, IWERUY, LOFLAV, BOKHIU, BOKJAO, BOKHAM, LODGAO, ESAWEC, YASGOQ04, BOKHEQ, YASGOQ02, YASGOQ01, TARPIO, VARGAZ, YASGOQ, TARPIO02, NOLBEY, ESAVIF, LODGAO02, FURSEM18, FURSEM16, FURSEM17, FURSEM14, FEFYIA, BOKHOA, LUTBOU, NOLBIC, FURSEM13, FURSEM01, ESAWAY, FEFYAS, ESAWIG, FEFYEW, XIFRAH, BUQTEP, SARQUB, SARQOV |
COD | 4509860, 4509862, 4509913, 4509914, 4509915, 4502989, 4502992, 4502990, 4502991, 7119123, 7218156, 7218157, 7218158, 1551859, 1551858, 1551860 |